What We Know From 4-Plus Years of Drug Patent Challenges Heard by the PTAB
This article was originally published at https://www.drugpatentwatch.com/blog/what-we-know-from-4-plus-years-of-drug-patent-challenges-heard-by-the-ptab/
While the Patent Trial and Appeal Board invalidates Orange Book-listed patents less than 20 percent of the time, it accepts 66 percent of petitions from generic drugmakers and takes no…
The post What We Know From 4-Plus Years of Drug Patent Challenges Heard by the PTAB appeared first on DrugPatentWatch.
Comments are closed.